BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19

• 

  Funding

  Memento brings home $93M series A souvenir, picks up bispecific for eye diseases

  Memento’s lead asset is a bispecific antibody that blocks VEGF and activates Tie2. The biotech plans to test the candidate in retinal conditions such as neovascular age-related macular degeneration and diabetic macular edema.

  June 19, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Adcomms

  Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership

  The FDA in February briefly refused to review Moderna’s flu vaccine, citing trial inadequacies, but reversed course a few days later. A verdict is expected by Aug. 5.

  June 19, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Government

  US launches investigation into German drug pricing, citing unfair R&D burden

  The U.S. government has argued that it pays too much of biopharma R&D costs, demanding that other high-income countries contribute fairly to global innovation efforts.

  June 19, 2026

   · 

  2 min read

   · 

  Gabrielle Masson
• 

  FDA

  Denali sells FDA voucher for $195M to support neurodegenerative pipeline

  Denali Therapeutics is the latest company to sell a priority review fast pass for an elevated price after the program was renewed earlier this year.

  June 19, 2026

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Regulatory

  FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’

  While drugmakers and other stakeholders want to see faster approvals, experts say the FDA’s Commissioner’s National Priority Voucher program is still bereft of important details, with candidate selection and interference from the agency’s senior leaders topping the list.

  June 19, 2026

   · 

  7 min read

   · 

  Michael Gibney
• Press Releases

  Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma

  June 19, 2026

   · 

  7 min read
• Press Releases

  MedTech Innovator Welcomes Dr. Jeffrey Shuren as Advisor

  June 19, 2026

   · 

  2 min read
• Press Releases

  CenExel Appoints Bethany Sensenig as Chief Financial Officer

  June 19, 2026

   · 

  2 min read
• Press Releases

  CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress

  June 19, 2026

   · 

  6 min read
• Press Releases

  ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing

  June 19, 2026

   · 

  4 min read